Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists - 1 Jul 2004

Watanabe Jun, Nishizaki Ritsuko, Jobo Toshiko, Kamata Yuko, Hata Hiroki, Nishimura Yukari, Fujisawa Takeshi, Okayasu Isao, Kuramoto Hiroyuki

Abstract excerpt

p14 activates p53 by inhibiting MDM2 expression and arrests the cell cycle in G1 and G2/M. Abnormal p14 expression has been reported in various human cancers. This study investigated p14 expression in endometrioid adenocarcinoma of the uterine corpus in an attempt to clarify its correlation with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Endometrioid
Share to Endometrial Hyperplasia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Genes, Tumor Suppressor

Share to Polymorphism, Single-Stranded Conformational

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to Tumor Suppressor Protein p14ARF

Source

Identifiers

PMID: 15213599
DOI: 10.1097/01.pgp.0000130050.27266.9a

Genes

MDM2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15213599-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus.PMID 15213599Read ↗

Relationship between p53 pathway and estrogen receptor status in endometrioid-type endometrial cancer.Semantic proximity Read ↗

Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis.Semantic proximity Read ↗

Alteration of G2 cell cycle regulators occurs during carcinogenesis of the endometrium.Semantic proximity Read ↗

Distinctive p53 and mdm2 Immunohistochemical Expression Profiles Suggest Different Pathogenetic Pathways in Poorly Differentiated Endometrial CarcinomaSemantic proximity Read ↗

Extremely well-differentiated adenocarcinoma of the stomach: clinicopathological and immunohistochemical features.Semantic proximity Read ↗

P16/MTS1 and pRB expression in endometrial carcinomas.Semantic proximity Read ↗

Expression and Prognostic Value of the Cell-cycle Regulatory Proteins, Rb, p16MTS1, p21WAF1, p27KIP1, Cyclin E, and Cyclin D2, in Ovarian CancerSemantic proximity Read ↗

Progressive derailment of cell cycle regulators in endometrial carcinogenesisSemantic proximity Read ↗

Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.